{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:38:54Z","timestamp":1782167934381,"version":"3.54.5"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["Grant number IN-US-334-4492, June 1st 2018"],"award-info":[{"award-number":["Grant number IN-US-334-4492, June 1st 2018"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background &amp;amp; Objective<\/jats:title><jats:p>Access to Hepatitis C (HCV) care remains suboptimal. This systematic review sought to identify existing interventions designed to improve direct-acting antiviral (DAA) uptake among HCV infected women, people who inject drugs (PWID), men who have sex with men (MSM), and Indigenous peoples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Studies published in high- and middle-income countries were retrieved from eight electronic databases and gray literature (e.g., articles, research reports, theses, abstracts) were screened by two independent reviewers. Identified interventions were summarized using textual narrative synthesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After screening 3,139 records, 39 studies were included (11 controlled comparative studies; 36 from high-income countries). Three groups of interventions were identified: interventions involving patients; providers; or the healthcare system. Interventions directed to patients included care co-ordination, accelerated DAA initiation, and patient education. Interventions involving providers included provider education, telemedicine, multidisciplinary teams, and general practitioner-led care. System-based interventions comprised DAA universal access policies and offering HCV services in four settings (primary care, secondary care, tertiary care, and community settings). Most studies (30\/39) described complex interventions, i.e., those with two or more strategies combined. Most interventions (37\/39) were tailored to, or studied among, PWID. Only one study described an intervention that was aimed at women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Combining multiple interventions is a common approach for supporting DAA initiation. Three main research gaps were identified, specifically, a lack of: (1) controlled trials estimating the individual or combined effects of interventions on DAA uptake; (2) studies in middle-income countries; and (3) interventions tailored to women, MSM, and Indigenous people.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.877585","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T05:36:30Z","timestamp":1656048990000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Interventions to Improve Uptake of Direct-Acting Antivirals for Hepatitis C Virus in Priority Populations: A Systematic Review"],"prefix":"10.3389","volume":"10","author":[{"given":"David","family":"Ortiz-Paredes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afia","family":"Amoako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taline","family":"Ekmekjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lebouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina B.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"B1","unstructured":"Hepatitis C. Geneva.2021"},{"key":"B2","unstructured":"Combating Hepatitis B and C to Reach Elimination by 2030 Geneva, Switzerland.2016"},{"key":"B3","unstructured":"Blueprint Writing Committee and Working GroupsBlueprint to Inform hepatitis C Elimination Efforts in Canada Montreal, QC.2019"},{"key":"B4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.29811","article-title":"Direct-acting antiviral sustained virologic response: impact on mortality in patients without advanced liver disease","volume":"68","author":"Backus","year":"2018","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/jvh.12985","article-title":"Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV\/Hepatitis C co-infected individuals","volume":"25","author":"Saeed","year":"2018","journal-title":"J Viral Hepat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination\u2014A path to global elimination of hepatitis C","volume":"67","author":"Lazarus","year":"2017","journal-title":"J Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/14659890601010373","article-title":"Gender differences in seeking care for hepatitis C in Australia","volume":"12","author":"Temple-Smith","year":"2007","journal-title":"J Subst Use."},{"key":"B9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eimc.2014.07.012","article-title":"Hepatitis C virus infection and its relationship to certain sexual practices in men-who-have-sex-with-men in Spain: results from the European MSM internet survey (EMIS)","volume":"33","author":"Fern\u00e1ndez-D\u00e1vila","year":"2015","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12879-019-3945-z","article-title":"Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015","volume":"19","author":"Vaux","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/QAD.0000000000001789","article-title":"Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV","volume":"32","author":"Pradat","year":"2018","journal-title":"AIDS"},{"key":"B12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3138\/canlivj.2018-0011","article-title":"Contextualizing Canada's hepatitis C virus epidemic","volume":"1","author":"Krajden","year":"2018","journal-title":"Can Liver J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/sextrans-2012-050566","article-title":"Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review","volume":"88","author":"Yaphe","year":"2012","journal-title":"Sex Transm Infect."},{"key":"B14","first-page":"e488","article-title":"First nations hepatitis C virus infections: six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario","volume":"63","author":"Gordon","year":"2017","journal-title":"Can Fam Physician."},{"key":"B15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/14461242.2015.1126187","article-title":"Multiple stigmas, shame and historical trauma compound the experience of aboriginal Australians living with hepatitis C","volume":"25","author":"Treloar","year":"2016","journal-title":"Health Sociol Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.socscimed.2014.01.043","article-title":"Historical trauma as public narrative: a conceptual review of how history impacts present-day health","volume":"106","author":"Mohatt","year":"2014","journal-title":"Soc Sci Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"E1352","DOI":"10.1503\/cmaj.160778","article-title":"The cedar project: mortality among young indigenous people who use drugs in British Columbia","volume":"189","author":"Jongbloed","year":"2017","journal-title":"Can Med Assoc J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.3390\/v4123912","article-title":"Hepatitis C virus in American Indian\/Alaskan native and aboriginal peoples of North America","volume":"4","author":"Rempel","year":"2012","journal-title":"Viruses."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e25013","DOI":"10.1002\/jia2.25013","article-title":"Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada","volume":"20","author":"Saeed","year":"2017","journal-title":"J Int AIDS Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e204192","DOI":"10.1001\/jamanetworkopen.2020.4192","article-title":"Assessment of treatment strategies to achieve hepatitis C elimination in Canada using a validated model","volume":"3","author":"Binka","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int J Drug Policy."},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","article-title":"Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: a systematic review","volume":"57","author":"Kronfli","year":"2018","journal-title":"Int J Drug Policy."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B24","unstructured":"World Economic Situation Prospects 2019.2019"},{"key":"B25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13643-019-1188-0","article-title":"How should systematic reviewers handle conference abstracts? A view from the trenches","volume":"8","author":"Scherer","year":"2019","journal-title":"Syst Rev"},{"key":"B26","unstructured":"HigginsJ\n            ThomasJ\n            ChandlerJ\n            CumpstonM\n            LiT\n            PageM\n          10.1002\/978111953660435352103Cochrane Handbook for Systematic Reviews of Interventions.2019"},{"key":"B27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2288-7-4","article-title":"Worked examples of alternative methods for the synthesis of qualitative and quantitative research in systematic reviews","volume":"7","author":"Lucas","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jclinepi.2019.03.008","article-title":"Improving the content validity of the mixed methods appraisal tool: a modified e-Delphi study","volume":"111","author":"Hong","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"B30","unstructured":"Items to be Included When Reporting Observational Studies in a Conference Abstract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.drugpo.2019.07.002","article-title":"An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: the ENHANCE study","volume":"72","author":"Alavi","year":"2019","journal-title":"Int J Drug Policy."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S737","DOI":"10.1016\/S0168-8278(17)31964-5","article-title":"Results of hepatitis C treatment program among people who inject drugs","volume":"66","author":"Filippovych","year":"2017","journal-title":"J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drugpo.2017.07.023","article-title":"Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: an evaluation of programmatic and treatment outcomes","volume":"47","author":"Mazhnaya","year":"2017","journal-title":"Int J Drug Policy."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/add.14978","article-title":"Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England","volume":"115","author":"Ward","year":"2020","journal-title":"Addiction."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/add.14569","article-title":"The hepatitis C awareness through to treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England","volume":"114","author":"Harrison","year":"2019","journal-title":"Addiction."},{"key":"B36","unstructured":"PluyeP\n            HongQN\n          About the MMAT.2019"},{"key":"B37","doi-asserted-by":"publisher","first-page":"874","DOI":"10.5604\/01.3001.0010.5277","article-title":"Direct-acting antiviral therapy outcomes in Canadian chronic hepatitis C telemedicine patients","volume":"16","author":"Cooper","year":"2017","journal-title":"Ann Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/jvh.13274","article-title":"Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care","volume":"27","author":"Falade-Nwulia","year":"2020","journal-title":"J Viral Hepat."},{"key":"B39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/cid\/ciz546","article-title":"Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomized controlled trial in people who inject drugs","volume":"22","author":"Wade","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S2468-1253(20)30120-5","article-title":"Clinical effectiveness of pharmacist-led vs. conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomized trial","volume":"5","author":"Radley","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B41","first-page":"934A","article-title":"Hepatitis C nurse as a case manager in people who inject drugs","volume":"68","author":"Bielen","year":"2018","journal-title":"Hepatology."},{"key":"B42","first-page":"S52","article-title":"Establishing access to hepatitis C treatment in a nurse practitioner-led community-based syringe acces center in San Francisco","volume":"45","author":"Crouch","year":"2018","journal-title":"Sex Transm Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"108025","DOI":"10.1016\/j.jsat.2020.108025","article-title":"Hepatitis C cascade of care at an integrated community facility for people who inject drugs","volume":"114","author":"Morris","year":"2020","journal-title":"J Subst Abuse Treat."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3138\/canlivj.1.2.002","article-title":"Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject drugs in vancouver's downtown eastside","volume":"1","author":"Alimohammadi","year":"2018","journal-title":"Can Liver J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"ofy048","DOI":"10.1093\/ofid\/ofy048","article-title":"Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program","volume":"5","author":"Eckhardt","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1016\/S0168-8278(17)30905-4","article-title":"Feasibility and acceptability of a group medical visit intervention to improve hepatitis C virus treatment uptake among persons who inject drugs (PWID) in a primary care setting","volume":"66","author":"Norton","year":"2017","journal-title":"J Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0618-8278(19)30978-8","article-title":"The impact of community-based rapid point-of-care testing on enhancing uptake of hepatitis C treatment for people who inject drugs in needle and syringe services","volume":"34","author":"Howell","year":"2019","journal-title":"J Gastroenterol Hepatol."},{"key":"B48","first-page":"73","article-title":"Eliminating hepatitis C by 2030: hospital presentation provides opportunities for engagement and treatment of marginalized individuals with chronic hepatitis C","volume":"34","author":"Freeman","year":"2019","journal-title":"J Gastroenterol Hepatol."},{"key":"B49","article-title":"Effect of a single-day investigation for HCV infection on treatment initiation among people who inject drugs (PWID)","author":"Martel-Laferriere","year":"2019","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S0618-8278(19)30973-9","article-title":"Community-based hepatitis C treatment of people who inject drugs and their injecting network is feasible and effective: results from the TAP (treatment and prevention) study","volume":"70","author":"Doyle","year":"2019","journal-title":"J Hepatol."},{"key":"B51","first-page":"417A","article-title":"Zooming to a cure: harnessing telemedicine to offer mobile hepatitis C testing and treatment","volume":"72","author":"Wungjiranirun","year":"2020","journal-title":"Hepatology."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13634","article-title":"Point-of-care hepatitis C testing and treating strategy in people who inject drugs in harm reduction and addiction centers for hepatitis C elimination","author":"Forns","year":"2020","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/ciy899","article-title":"Integrated, Co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone","volume":"69","author":"Talal","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.1016\/S0168-8278(20)31117-X","article-title":"Improving female street sex worker (FSSW) access to hepatitis C testing and treatment","volume":"73","author":"Wigglesworth","year":"2020","journal-title":"J Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"956A","DOI":"10.1016\/j.dld.2018.11.150","article-title":"Models of care for the management and treatment of hepatitis C virus infection among people who inject drugs","volume":"70","author":"Conti","year":"2019","journal-title":"Hepatology."},{"key":"B56","first-page":"80","article-title":"How well-used, effective, and safe is general practitioner prescription of hepatitis C therapy?","volume":"32","author":"Deriviere","year":"2017","journal-title":"J Gastroenterol Hepatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/imj.14072","article-title":"Hepatitis C treatment for difficult to access populations: can telementoring (as distinct from telemedicine) help?","volume":"49","author":"Mohsen","year":"2019","journal-title":"Intern Med J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.drugpo.2019.02.012","article-title":"Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia","volume":"72","author":"Harney","year":"2019","journal-title":"Int J Drug Policy."},{"key":"B59","doi-asserted-by":"publisher","first-page":"S271","DOI":"10.1016\/S0168-8278(18)30757-8","article-title":"Multidisciplinary support program for patients with addictions and suspected chronic hepatitis C (MSP ADIC-C) to improve their evaluation and access to antiviral treatment","volume":"68","author":"Puigvehi","year":"2018","journal-title":"J Hepatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1093\/ofid\/ofx163.396","article-title":"Implementation of a comprehensive hepatitis C virus (HCV) treatment program in metro-detroit","volume":"4","author":"Awali","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B61","article-title":"Direct-acting antiviral therapy in primary care following non-real time, remote specialist review-a practical solution to scaling up HCV therapy","author":"Thomas","year":"2018","journal-title":"Hepatology"},{"key":"B62","first-page":"611A","article-title":"Increased intensity of testing and treatment for elimination of hepatitis C real world experience from the treatment as prevention (TRAP HEPC) program in Iceland","volume":"66","author":"Gottfredsson","year":"2017","journal-title":"Hepatology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/cid\/ciz833","article-title":"Eliminating structural barriers: the impact of unrestricted access on hepatitis C treatment uptake among people living with HIV","volume":"71","author":"Saeed","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0235445","DOI":"10.1371\/journal.pone.0235445","article-title":"The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services","volume":"15","author":"Traeger","year":"2020","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/cid\/ciz985","article-title":"Moving toward hepatitis C microelimination among people living with human immunodeficiency virus in Australia: the CEASE study","volume":"71","author":"Martinello","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B66","first-page":"292","article-title":"Success of unrestricted DAA therapy is limited by HCV reinfections and loss to follow-up in HIV-positive patients","volume":"20","author":"Chromy","year":"2019","journal-title":"HIV Med."},{"key":"B67","first-page":"399A","article-title":"Changes in characteristics of patients with chronic hepatitis C (CHC) and effectiveness of treatment uptake after universal access to direct-acting antivirals (DAAS) a greek paradigm on the path of elimination","volume":"70","author":"Vasileiadi","year":"2019","journal-title":"Hepatology."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)00920-X","article-title":"Case management to improve uptake for screening and therapy of hepatitis C viral infection in people who inject drugs","author":"Bielen","year":"2016","journal-title":"Hepatology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"S1192","DOI":"10.1016\/S0016-5085(19)39957-3","article-title":"Point-of-care hepatitis C screening and open access clinic improves linkage to care and treatment uptake among ex drug users population in Singapore: a cluster randomized study","volume":"156","author":"Hsiang","year":"2019","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"A108","DOI":"10.1136\/gutjnl-2019-BSGAbstracts.206","article-title":"Treating in chaos: outcomes of hepatitis C treatment in newcastle's homeless drug users","volume":"68","author":"Buchanan","year":"2019","journal-title":"Gut."},{"key":"B71","doi-asserted-by":"publisher","first-page":"103247","DOI":"10.1016\/j.drugpo.2021.103247","article-title":"Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: a knowledge synthesis","volume":"96","author":"Amoako","year":"2021","journal-title":"Int J Drug Policy"},{"key":"B72","doi-asserted-by":"publisher","first-page":"CD009987","DOI":"10.1002\/14651858.CD009987.pub2","article-title":"Decentralizing HIV treatment in lower- and middle-income countries","volume":"6","author":"Kredo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2471\/BLT.17.193375","article-title":"Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"95","author":"Ho","year":"2017","journal-title":"Bull World Health Organ."},{"key":"B74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugpo.2017.05.022","article-title":"Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia","volume":"47","author":"Iversen","year":"2017","journal-title":"Int J Drug Policy."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/liv.14043","article-title":"Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting","volume":"39","author":"Soc\u00edas","year":"2019","journal-title":"Liver Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.drugalcdep.2018.11.026","article-title":"Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle","volume":"195","author":"Tsui","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drugpo.2018.08.012","article-title":"Variation in hepatitis C virus treatment uptake between Canadian centers in the era of direct-acting antivirals","volume":"65","author":"Nitulescu","year":"2019","journal-title":"Int J Drug Policy."},{"key":"B78","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jvh.12852","article-title":"Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia","volume":"25","author":"Hajarizadeh","year":"2018","journal-title":"J Viral Hepat."},{"key":"B79","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/MCG.0000000000000857","article-title":"Uptake of and factors associated with direct-acting antiviral therapy among patients in the chronic hepatitis cohort study, 2014\u20132015","volume":"52","author":"Spradling","year":"2018","journal-title":"J Clin Gastroenterol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10654-014-9958-4","article-title":"Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis","volume":"30","author":"Aspinall","year":"2015","journal-title":"Eur J Epidemiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/eurpub\/ckt156","article-title":"Effectiveness of interventions to increase hepatitis C testing uptake among high-risk groups: a systematic review","volume":"24","author":"Jones","year":"2013","journal-title":"Eur J Public Health."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health."},{"key":"B83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12916-018-1246-9","article-title":"Challenges and opportunities in examining and addressing intersectional stigma and health","volume":"17","author":"Turan","year":"2019","journal-title":"BMC Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.877585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T05:36:44Z","timestamp":1656049004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.877585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":83,"alternative-id":["10.3389\/fpubh.2022.877585"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.877585","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"877585"}}